Deadline for Abstract Submission: August 25, 2025

Abstract submission will be subject to ‘Double blind peer review’.

Abstract Submission Details

• Deadline for submission of abstracts is 23:59 hrs, August 25, 2025
• Abstract announcement will be made on September 3, 2025
• Abstracts must be original.
• Abstracts must be limited with 300 words.
• Abstract submission deadline must be strictly observed. Papers submitted after the deadline will not be admitted.
• The Scientific Committee may chose to admit abstracts as full text, oral and/or poster presentations. Abstract holders will be informed on this choice.
• Abstract holders and authors listed on the paper must make sure that they reach an agreement on the latest version of the paper. The papers must be uploaded on the submission system only after such agreement is made.
• The person to make the presentation must be registered for the congress as participant.

Preparing the Abstract

• Please read the following steps before starting:
• Poster presentations will be in digital format.
• You must fully enter the correspondence information of the presenter.
• E-mail address
• Address details
• Telephone numbers for daytime and evening.
• Information on the author and co-authors must be entered in detail.
• Full names and surnames
• Author’s name must include uppercase and lowercase letters. (J. Kaya)
• Name of the institution must be entered in the following order: department, institute/hospital, city, country
• Abstract title must be confined with 30 words and must be entered in UPPERCASE letters.
• Your abstract must be composed of 300 words including “Acknowledgements”
  

  PLEASE NOTE: We highly advise use of Office software for formulating, editing and word counting of your abstract (such as the Word’s word counter, etc.)

• Please include the following paragraphs in your research abstracts:
  • Objective
  • Methods
  • Findings
  • Discussion
  • Result
• Please include the following paragraphs for case reports:
  • Objective
  • Case presentation
  • Discussion
  • Result
• Please use only standard abbreviations. Any special annotation or unexpected abbreviations must be explained within brackets.
• Names of medications must be indicated with respective brands. Amounts must be given in quantities.
• Abstracts should not contain any tables and figures.
• Elaboration
• The author must clarify any and all disclosures. Any service linked to any producer/supplier or business of any commercial products must be indicated in the proper box on the presentation form.

Rules for Writing Abstracts

TURKISH TITLE (12-POINT FONT SIZE, BOLD, CENTERED, ALL IN UPPERCASE)
English Title (12-Point font size, Centered, First letters in uppercase)

Name SURNAME (11-point font size, Name – Only first letter in uppercase, Surname – All in uppercase, bold, centered)
Title, University, Faculty, Department (10-point font size, centered, italic)
E-mail (10- point font size, centered, italic)

Core Message: (Turkish, aligned, 11-point font size) The subject, objective, method, findings and result must be embodied in the abstract. The abstract must be confined with one page including the English paragraph.

Rules for Writing the Full Text

1. The full text must be confined with 6 pages.
2. Content of the full text must follow the following order: Turkish title, English title, Turkish abstract and key words, main text, results, references, annexes, if any (figures, etc). Abstracts must be 250 words, and the key words must be between 3-5 words.
   The text must be arranged to contain Introduction (200-500 words), Tools and Methods (max. 800 words), Findings (max. 800 words), Discussion (max. 1200 words) and References (max.30).
3. Page Setup: The full text must be written in Microsoft Word and the page setup must be arranged as follows:
4. Author’s title, name and surname must be given in 11-point font size at the bottom right of the title. Institution and e-mail address of the author must be indicated in 9-point font size under the trimline given for footnotes on the same page.
5. The main title and subtitles of the text must be numbered in 12-point font size in bold and left aligned letters. All letters of the main title must be in uppercase whereas only the first letters of the subtitles must be written in uppercase. The titles must be structured up to 4 levels. 1 line of space must be given before the main title, but no space should be given after the title. There should be no space line either before or after the subtitles. Please use 11-point font size for this part.
6. All tables, figures and graphs within the text must be centered in a consecutively numbered setup indicated properly on the text. All tables, figures or graphs must be titled. The title must be written above the respective table, figure or graph, must be centered, and written in 10-point font size with only the first letters in uppercase. Any text within the table, figure and graph must be between a font size of 8-10 points. Tables, figures or graphs must be easily legible and should fit in the above explained page structure (not exceeding paper margins).
7. For referencing within and at the end of the text, AMA (American Medical Association) style must be used. Any and all references used in the text must be indicated in the References part. References must be superscripted in the order of appearance in the text. i.e. "as explained in ….8 ". If previously used, the reference must be indicated with the same number.

IMPORTANT NOTES

• Abstracts will only be submitted online. Any abstract mailed or e-mailed out of the online system will be rejected.
• For any abstract to be included in the online abstract book, its author must be registered for the congress. This obligation does not apply to other authors.
• The name of the author to present the paper must match with the name of the participant uploading the abstract on the system.
• The entire evaluation process of the abstracts can be tracked through emails.
• To avoid any communication problem about your paper, do not forget to enter your e-mail address and mobile number whilst getting registered on the system. Papers without correspondence info will not be taken into evaluation.
• Authors may chose “oral” and/or “poster” presentation for their papers, however the Scientific Committee may change the way of presentation based on peer review opinion.
• Members of the Scientific Committee will evaluate submitted papers for compliance of their scientific quality.
• Acceptance process of all submitted papers will be subject to confidential peer review after the deadline for submission. Acceptance letters will be e-mailed to authors upon approval.
• The Organizing Committee and Center Events shall by no means be held liable for any missing and/or misleading information.
• You may submit your requests for correction at dopek2025@centerevents.com.tr before the deadline for submission of abstracts. Requests submitted after the deadline will not be considered.
• Abstracts not following the Rules for Writing Abstracts and the above explained criteria will be excluded from evaluation.